Alert for contaminated Valsartan, ask not to consume it

The Federal Commission for Protection against Health Risks (Cofepris) ordered the recall of Valsartan manufactured by the Zhejiang Huahai Pharmaceutical Co. Ltd. company based in China, C & # 39; is after the manufacturing company detects an impurity generated by the product synthesis method.

Valsartan is the active substance present in drugs used for the treatment of heart failure and antihypertensive.

See also: Withdrawal of contraceptives in the United States due to a packaging error

release Cofepris investigation of Mexican companies that use it to immobilize the product and not for the market.

This notification has affected several countries, so that COFEPRIS through its international cooperation programs, will join the sanitary control actions that correspond to avoid any risk to the population

To read also: Antibiotics: when and how?

The products identified up to here that contain the Valsartan raw material from the manufacturer Zhejiang Huahai Pharmaceutical Co. Ltd., are as follows:

It is important to emphasize that these products are removed from the market, so if you have them, you can contact the laboratories that appear as owners of the file in the previous table, to determine the mechanism

Recommendations:

• Patients: If you use any of the drugs with the active ingredient Valsartan before It is recommended not to suspend treatment and to go to the doctor to obtain the prescription of an alternative drug with the same function according to treatment done
• Doctors: Review the treatments and replace the drug with another. with the same composition or therapeutic indication that is not part of the withdrawal made by this Authority.
• Pharmacies: Upon presentation of a prescription with the active ingredient Valsartan, ask the patient to consult his doctor and not to suspend treatment. COFEPRIS will verify that the above-mentioned drugs are not marketed.

In this note: